Industry News
Centralisation To Fewer Surgeons Results In Better Survival After Oesophageal Cancer Surgery
Jan 10, 2013
Patients who undergo surgery for oesophageal cancer have a much greater chance of long term survival if the operation is carried out by a surgeon who has performed this particular operation many times before. This according to a new, large-scale study conducted by researchers at Karolinska Institutet in Sweden, which is published in the Journal of Clinical Oncology... Read More
Cancer Screening Unlikely To Benefit Patients With A Short Life Expectancy
Jan 10, 2013
Less than 10 years and risks are likely to outweigh benefits Breast and colorectal cancer screening should be targeted towards patients with a life expectancy greater than 10 years: for any shorter life expectancy the harms are likely to outweigh the benefits, concludes a study published on bmj.com today... Read More
Surprising Influences On Cancer Screenings Revealed By First Study Of Oregon's Hmong
Jan 10, 2013
Cervical cancer rates for Hmong women are among the highest in the nation, yet past research has shown that cervical and breast cancer screening rates for this population are low - in part because of the Hmong's strong patriarchal culture... Read More
Genetic Region Linked To Control Of Key Blood-Clotting Protein Discovered Through Sibling Study
Jan 10, 2013
In 2006, the lab of Dr. David Ginsburg at the Life Sciences Institute put a call out for siblings attending the University of Michigan to donate blood for a study of blood-clotting disorders. The samples were collected over three years and have now enabled the researchers to identify the specific parts of the genome responsible for levels of a key substance for blood clotting... Read More
BMJ Raises Concerns Over The Effectiveness Of A Costly And Invasive Procedure For Melanoma
Jan 10, 2013
BMJ Editor says all trials must be registered and the results published A special report published by the BMJ today finds that thousands of melanoma patients around the world are undergoing an expensive and invasive procedure called sentinel node biopsy, despite a lack of clear evidence and concerns that it may do more harm than good... Read More
New Cervical Cancer Screening Guidelines Released Screening Should Begin At Age 25 And Be Conducted Every 3 Years
Jan 10, 2013
Routine screening of women for cervical cancer should begin at age 25 and be conducted at 3-year intervals, recommend new screening guidelines from the Canadian Task Force on Preventive Health Care published in CMAJ (Canadian Medical Association Journal).The guidelines also recommend screening for women aged 70 years and older who have not been adequately screened in the past... Read More
Surprising Influences On Cancer Screenings Revealed By First Study Of Oregon's Hmong
Jan 10, 2013
Cervical cancer rates for Hmong women are among the highest in the nation, yet past research has shown that cervical and breast cancer screening rates for this population are low - in part because of the Hmong's strong patriarchal culture... Read More
Cancer Death Rates Have Fallen Over The Last Decade
Jan 09, 2013
Overall cancer death rates in the U.S. have been steadily declining, according to latest data gathered from The Annual Report to the Nation on the Status of Cancer. The report, which analyzed the number of deaths caused by cancer from 1975-2009, has shed light on the extent of the country's success in its battle against cancer... Read More
Provectus Pharmaceuticals Announces H. Lee Moffitt Cancer Center Initiates Phase 1 Study Of PV-10 To Elucidate Bystander Effect
Jan 09, 2013
Provectus Pharmaceuticals, Inc. (OTCBB: PVCT), a development-stage oncology and dermatology biopharmaceutical company, reports that the Moffitt Cancer Center has initiated a Phase 1 study to investigate potential immune biomarkers in both tumor tissue and peripheral blood after intralesional ("IL") PV-10 injection of melanoma tumors. Amod Sarnaik, M.D... Read More
Novel Hypothesis On Curing Late-Stage Cancers Published By Nobel Laureate James Watson
Jan 09, 2013
"Although mortality from many cancers has been steadily falling, particularly those of the blood [i.e., leukemias], the more important statistic may be that so many epithelial cancers (carcinomas) and effectively all mesenchymal cancers (sarcomas) remain largely incurable." With these words as preface, Nobel laureate James D. Watson, Ph.D... Read More
Previous Page Next Page